Cerevance Media Center

Current News

August 28, 2023

Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023

Cerevance has been named by Fierce Biotech as one of the most promising early-stage biotechnology companies in the industry in 2023, showcased on this year’s Fierce 15 list.

READ FULL

July 10, 2023

Cerevance to Present at the Alzheimers Association International Conference

Cerevance to present a poster presentation at the upcoming Alzheimer’s Association International Conference (AAIC), taking place in Amsterdam, Netherlands, July 16 – 20, 2023.

READ FULL

May 16, 2023

Oral Presentation of Phase 1 Data on CVN766 at American Society of Clinical Psychopharmacology (ASCP)

Cerevance to present an oral presentation at the upcomingAmerican Society of Clinical Psychopharmacology (ASCP) conference, taking place in Miami, Florida, May 30 – June 2, 2023.

READ FULL

May 9, 2023

Cerevance to Present at Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development

Cerevance today announced plans to present at the upcoming Neurodegeneration: New Biology Guiding the NextGeneration of Therapeutic Development conference, taking place in British Columbia, Canada, May 15 – 19, 2023.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

April 13, 2023

BNA International Festival of Neuroscience

Date:
Sunday, April 23, 2023
Time:
2:40pm-4:20pm
Location:
Brighton, United Kingdom
Media:
Poster
Read full

April 10, 2023

Needham Healthcare Conference

Date:
Thursday, April 20, 2023
Time:
2:15pm – 2:55 pm
Location:
Virtual Conference
Media:
Presentation
Read full

March 27, 2023

Chief Medical Officer Summit 360˚

Date:
Monday, April 3, 2023
Time:
1:00 pm - 2:00 p.m. ET
Location:
Boston, MA at Boston Park Plaza
Media:
Panel Discussion
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

October 21, 2024

CVN424, a GPR6 Inverse Agonist, for Parkinson’s Disease and Motor Fluctuations: A Double-Blind, Randomized, Phase 2 Trial

Brice, Nicola L., Carlton, Mark, Margolin, David H., Bexon, Martin, Matthews, Kim L., Dawson, Lee A., Ellenbogen, Aaron L., Olanow, Warren C., Dubow, Jordan, and Kieburtz, Karl

Viewview

April 30, 2022

A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease

Margolin, D.H., Brice, N.L., Davidson, A.M., Matthews, K.L., Carlton, M.B.L.

Viewview

June 30, 2021

Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease

Brice, N.L., Schiffer, H.H., Monenschein, H., Mulligan, V.J., Page, K., Powell, J., Xu, X., Cheung, T., Burley, J.R., Sun, H., Dickson, L., Murphy, S.T., Kaushal, N., Sheardown, S., Lawrence, J., Chen, Y., Bartkowski, D., Kanta, A., Hosea, N., Dawson, L.A., Hitchcock, S.H., Carlton, M.B.

Viewview

March 1, 2024

Discovery and First-time Disclosure of CVN766, an Exquisitely Selective Orexin 1 Receptor Antagonist

Glen, A., Bürli, R.W., Livermore, D., Buffham, W., Merison, S., Rowland, A.E., Newman, R., Fieldhouse, C., Miller, D.J., Dawson, L.A., Matthews, K., Carlton, M.B., Brice, N.L.

Viewview

April 5, 2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment

Bürli, R. W., Doyle,K. J., Dickson, L., Rowland, A., Matthews, K., Stott, A. J., Teall, M., Ossola, B., Russell, S. G., Harvey, J. R. M., Wu,Y., Narayana, L., Brice, N. L., Carlton, M., Dawson, L. A.

Viewview

February 15, 2023

Characterisation of C101248: A Novel Selective THIK-1 Channel Inhibitor for the Modulation of Microglial NLRP3-Inflammasome

Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M., Burley, R., Barke, D., Cadwalladr, D., Dickson, L., Lawrence, J., Harvey, J., Lizio, M., Xu, X., Kavanagh, E., Cheung, T., Sheardown, S., Lawrence, C.B., Harte, M., Brough, D., Madry, C., Matthews, K., Doyle, K., Page, K., Powell, J., Brice, N.L., Bürli, R.W., Carlton, M.B., Dawson L.A.

Viewview